Citadel Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,020
| Closed | -$385K | – | 6399 |
|
|
2024
Q4 | $385K | Buy |
+17,020
| New | +$385K | ﹤0.01% | 4267 |
|
|
2024
Q3 | – | Sell |
-39,045
| Closed | -$903K | – | 6187 |
|
|
2024
Q2 | $903K | Buy |
39,045
+17,658
| +83% | +$408K | ﹤0.01% | 3151 |
|
|
2024
Q1 | $515K | Sell |
21,387
-17,783
| -45% | -$428K | ﹤0.01% | 3866 |
|
|
2023
Q4 | $901K | Buy |
39,170
+18,361
| +88% | +$422K | ﹤0.01% | 3137 |
|
|
2023
Q3 | $423K | Buy |
+20,809
| New | +$423K | ﹤0.01% | 3928 |
|
|
2023
Q1 | – | Sell |
-15,654
| Closed | -$394K | – | 6201 |
|
|
2022
Q4 | $394K | Sell |
15,654
-21,473
| -58% | -$540K | ﹤0.01% | 4090 |
|
|
2022
Q3 | $980K | Buy |
+37,127
| New | +$980K | ﹤0.01% | 3443 |
|
|
2022
Q2 | – | Sell |
-16,584
| Closed | -$571K | – | 6430 |
|
|
2022
Q1 | $571K | Sell |
16,584
-66,870
| -80% | -$2.3M | ﹤0.01% | 4312 |
|
|
2021
Q4 | $3.66M | Buy |
83,454
+50,199
| +151% | +$2.2M | ﹤0.01% | 2414 |
|
|
2021
Q3 | $1.69M | Buy |
33,255
+4,240
| +15% | +$215K | ﹤0.01% | 3202 |
|
|
2021
Q2 | $1.51M | Sell |
29,015
-4,447
| -13% | -$231K | ﹤0.01% | 3550 |
|
|
2021
Q1 | $1.53M | Buy |
+33,462
| New | +$1.53M | ﹤0.01% | 3470 |
|
|
2020
Q4 | – | Sell |
-23,976
| Closed | -$934K | – | 5300 |
|
|
2020
Q3 | $934K | Sell |
23,976
-2,675
| -10% | -$104K | ﹤0.01% | 2973 |
|
|
2020
Q2 | $1.01M | Buy |
+26,651
| New | +$1.01M | ﹤0.01% | 2847 |
|